People with Type 2 or pregnancy-related diabetes would get blood sugar monitor coverage through plans with drug or medical equipment coverage, without a deductible but with follow-up care required.
Plans with drug or medical equipment coverage would cover medically needed blood sugar monitors and supplies for Type 2 or pregnancy-related diabetes, without a deductible. Keeping coverage would require follow-up care.
For Type 2 or pregnancy-related diabetes, insurers could not require insulin use, frequent testing, or advance approval for monitors. Their preferred lists would include at least two of each device type.
Patients with Type 2 or pregnancy-related diabetes would need follow-up care to keep monitor coverage: at least every six months for the first 18 months, then at least once a year.
Health plans would cover medically appropriate or necessary blood sugar monitors and supplies without a deductible. The requirement covers individual and group health insurance plans with drug or medical equipment coverage for people diagnosed with Type 2 or pregnancy-related diabetes. It includes standard and continuous blood sugar monitors. Patients could still owe copayments or a share of covered costs. Continued coverage would require follow-up care.
Insurers would cover these monitors without requiring insulin use, a certain testing frequency, or advance approval. These rules cover people with Type 2 or pregnancy-related diabetes in individual and group plans with drug or medical equipment coverage. A referral or prescription from an endocrinologist, a doctor who treats diabetes and other hormone conditions, would not be required. Preferred provider or covered-device lists would have to include at least two of each kind of device.
Patients would need follow-up care to keep their blood sugar monitor coverage. The requirement covers people with Type 2 or pregnancy-related diabetes receiving monitor coverage through individual or group plans with drug or medical equipment coverage. Patients could attend in person or through telehealth. Their treating licensed health professional would assess whether the monitor helps manage their diabetes. The visit schedule would begin when the patient starts using the monitor.
No hearings or votes scheduled.